The machine enables physicians to locate interventional instruments in relation to pre-acquired CT images, which can be analogous to just how a GPS locates an automobile using stored roadmaps. With today’s announcement, ActiViews further cements our commitment to become leading company of minimally invasive thoracic and abdominal medical oncology solutions, commented Christopher von Jako, President of ActiViews, Inc. Related StoriesBoston Scientific signs definitive agreement to obtain CeloNova's interventional radiology businessNew guidance statement on palliative caution to be presented in 2015 Palliative Care in Oncology SymposiumLilly expands existing immuno-oncology collaboration with AstraZenecaIn support of its FDA medical device submission for liver interventions, ActiViews concluded a safety and performance clinical trial in December in two hospitals affiliated with McGill University Wellness Middle in Montreal, Canada.The process was amended to allow entry of sufferers who had one lymph-node micrometastasis if an axillary dissection was finished and no further lymph-node involvement was detected. Other requirements included adequate hematopoietic and liver function and a remaining ventricular ejection fraction of 50 percent or greater. The institutional review panel at each participating organization approved the study. Written informed consent was provided by all the participants. The scholarly study was designed by the first author and the last two authors. Nobody who was no author contributed to the writing of the manuscript.